General Information of the Drug (ID: M6APDG01634)
Name
N-methyl ryanodine-succinamidate
Synonyms
N-methyl ryanodine-succinamidate; CHEMBL432278
    Click to Show/Hide
Status
Investigative
Structure
3D MOL
Formula
C30H42N2O11
InChI
1S/C30H42N2O11/c1-15(2)27(38)22(42-21(35)17-8-7-13-32-17)28(39)23(4)14-26(37)24(27,5)30(28,40)29(43-26)20(16(3)11-12-25(23,29)36)41-19(34)10-9-18(33)31-6/h7-8,13,15-16,20,22,32,36-40H,9-12,14H2,1-6H3,(H,31,33)/t16?,20-,22-,23+,24?,25?,26?,27?,28?,29?,30?/m1/s1
InChIKey
RWAKHARTDYCRMC-QYQZIFBLSA-N
PubChem CID
44275929
TTD Drug ID
D05VJH
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Ryanodine receptor 1 (RYR1)
Methyltransferase-like 16 (METTL16)
In total 1 mechanisms lead to this potential drug response
Response Summary Ryanodine receptor 1 (RYR1) is a therapeutic target for N-methyl ryanodine-succinamidate. The Methyltransferase-like 16 (METTL16) has potential in affecting the response of N-methyl ryanodine-succinamidate through regulating the expression of Ryanodine receptor 1 (RYR1). [1], [2]
References
Ref 1 Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017 Nov;18(11):2004-2014. doi: 10.15252/embr.201744940. Epub 2017 Oct 19.
Ref 2 Amino- and guanidinoacylryanodines: basic ryanodine esters with enhanced affinity for the sarcoplasmic reticulum Ca(2+)-release channel. J Med Chem. 1993 May 14;36(10):1319-23. doi: 10.1021/jm00062a003.